• Profile
Close

Reducing opioid utilization after urologic oncology surgery

Journal of Clinical Oncology Oct 04, 2018

Stevenson K, et al. - Given widespread abuse of opioid pain medications among Americans, with 6% of opioid-naïve patients becoming newly addicted to opioid medications following surgery, researchers aimed to lessen dependence on opioids to manage post-operative pain by 50% from a baseline morphine equivalent daily dose (MEDD) of 95.1 to a target of 47.5 MEDD. The implementation of opioid-minimizing approaches, including opioid-sparing pain regimens and interventions to facilitate adoption of the novel pathways, led to a reduction of 46% in opioid use following surgery without compromising pain control. To combat the opioid epidemic, health care providers can play a pivotal role by decreasing reliance on opioids in the post-operative period.

Methods

  • Participants were inpatients recovering from surgery for urologic cancers at the researchers’ institution over 4 months.
  • These subjects were retrospectively reviewed for daily opioid use, pain scores, and anxiety scores.
  • The causes contributing to excess opioid use were determined by generating process maps, Ishikawa diagrams, and Pareto charts.
  • Opioid-sparing pain regimens (using varying combinations of acetaminophen, ketorolac, gabapentin, and local anesthetic) were designed and key drivers needed to reliably reduce excess opioid use were also identified.
  • They also implemented initial interventions aimed at educating providers and nurses on availability and efficacy of non-opioid medications, and later, to facilitate adoption of the novel pathways.

Results

  • This QI project involved 443 patients.
  • Findings revealed that the median opioid use per patient decreased 46% from 95.1 to 51.5 MEDD over the course of this project.
  • Across multiple surgery types, ranging from robotic prostatectomy (55.1 MEDD) to open radical cystectomy (50.6 MEDD), this attenuation in opioid requirements was successfully achieved.
  • They observed no increase in 24- or 48-hour post-operative pain score related to use of opioid-minimizing pathways (3.03 vs 3.04 and 2.92 vs 2.96, respectively; p > 0.05 for both).
  • Similarly, no change was observed in anxiety score at 24- or 48-hours after surgery (0.15 vs 0.12 and 0.48 vs 0.30, respectively; p > 0.05 for both).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay